Podbielska et al., 2011 - Google Patents
The structural and functional role of myelin fast-migrating cerebrosides: pathological importance in multiple sclerosisPodbielska et al., 2011
View PDF- Document ID
- 13105566921182555911
- Author
- Podbielska M
- Levery S
- Hogan E
- Publication year
- Publication venue
- Clinical lipidology
External Links
Snippet
A family of neutral glycosphingolipids containing a 3-O-acetyl-sphingosine galactosylceramide (3-SAG) has been characterized. Seven new derivatives of galactosylceramide (GalCer), designated as fast-migrating cerebrosides (FMCs) by TLC …
- 201000006417 multiple sclerosis 0 title abstract description 117
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Shamshiev et al. | The αβ T cell response to self-glycolipids shows a novel mechanism of CD1b loading and a requirement for complex oligosaccharides | |
| Willison et al. | Peripheral neuropathies and anti‐glycolipid antibodies | |
| Lingwood | Glycosphingolipid functions | |
| McEwen-Smith et al. | CD1d-dependent endogenous and exogenous lipid antigen presentation | |
| Zajonc et al. | Structural basis for CD1d presentation of a sulfatide derived from myelin and its implications for autoimmunity | |
| Hakomori et al. | Functional role of glycosphingolipids in cell recognition and signaling | |
| Jahng et al. | Prevention of autoimmunity by targeting a distinct, noninvariant CD1d-reactive T cell population reactive to sulfatide | |
| De Libero et al. | Recognition of lipid antigens by T cells | |
| Plomp et al. | Pathophysiological actions of neuropathy‐related anti‐ganglioside antibodies at the neuromuscular junction | |
| Jennemann et al. | Cell-specific in vivo functions of glycosphingolipids: lessons from genetic deletions of enzymes involved in glycosphingolipid synthesis | |
| Schümann et al. | Differential alteration of lipid antigen presentation to NKT cells due to imbalances in lipid metabolism | |
| Rhost et al. | Identification of novel glycolipid ligands activating a sulfatide‐reactive, CD1d‐restricted, type II natural killer T lymphocyte | |
| Podbielska et al. | The structural and functional role of myelin fast-migrating cerebrosides: pathological importance in multiple sclerosis | |
| de Jong | Activation of human T cells by CD 1 and self‐lipids | |
| Podbielska et al. | Molecular and immunogenic features of myelin lipids: incitants or modulators of multiple sclerosis? | |
| Paget et al. | TLR9-mediated dendritic cell activation uncovers mammalian ganglioside species with specific ceramide backbones that activate invariant natural killer T cells | |
| Park et al. | Fine specificity of natural killer T cells against GD3 ganglioside and identification of GM3 as an inhibitory natural killer T‐cell ligand | |
| Goodfellow et al. | Gangliosides and autoimmune peripheral nerve diseases | |
| Pei et al. | Interplay between carbohydrate and lipid in recognition of glycolipid antigens by natural killer T cells | |
| Rakhshandehroo et al. | Invariant natural killer T cells in adipose tissue: novel regulators of immune-mediated metabolic disease | |
| Popovic et al. | Glucosylceramide synthase is involved in development of invariant natural killer T cells | |
| O’Konek et al. | Mouse and human iNKT cell agonist β-mannosylceramide reveals a distinct mechanism of tumor immunity | |
| Moody et al. | Glycolipid targets of CD1‐mediated T‐cell responses | |
| Zhou | The immunological function of iGb3 | |
| Dellabona et al. | Group 1 CD1‐restricted T cells and the pathophysiological implications of self‐lipid antigen recognition |